{"Symbol": "MRNA", "AssetType": "Common Stock", "Name": "Moderna Inc", "Description": "Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.", "CIK": "1682852", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "325 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142", "OfficialSite": "https://www.modernatx.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "16500681000", "EBITDA": "-2859000064", "PERatio": "None", "PEGRatio": "0", "BookValue": "22.07", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-7.26", "RevenuePerShareTTM": "4.997", "ProfitMargin": "-1.452", "OperatingMarginTTM": "-1.264", "ReturnOnAssetsTTM": "-0.145", "ReturnOnEquityTTM": "-0.289", "RevenueTTM": "1944000000", "GrossProfitTTM": "-2056000000", "DilutedEPSTTM": "-7.26", "QuarterlyEarningsGrowthYOY": "-0.851", "QuarterlyRevenueGrowthYOY": "-0.298", "AnalystTargetPrice": "40.95", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "2", "AnalystRatingHold": "18", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "2", "TrailingPE": "-", "ForwardPE": "32.47", "PriceToSalesRatioTTM": "8.49", "PriceToBookRatio": "1.769", "EVToRevenue": "6.15", "EVToEBITDA": "4.641", "Beta": "1.338", "52WeekHigh": "55.2", "52WeekLow": "22.28", "50DayMovingAverage": "36.74", "200DayMovingAverage": "29.35", "SharesOutstanding": "390734000", "SharesFloat": "365379000", "PercentInsiders": "7.411", "PercentInstitutions": "75.461", "DividendDate": "None", "ExDividendDate": "None"}